Suppr超能文献

老年女性临床腋窝淋巴结阴性且未行腋窝清扫时的保乳治疗

Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection.

作者信息

Wazer D E, Erban J K, Robert N J, Smith T J, Marchant D J, Schmid C, DiPetrillo T, Schmidt-Ullrich R

机构信息

Breast Health Center, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111.

出版信息

Cancer. 1994 Aug 1;74(3):878-83. doi: 10.1002/1097-0142(19940801)74:3<878::aid-cncr2820740314>3.0.co;2-4.

Abstract

BACKGROUND

A prospective study was initiated to explore an approach of limited therapy in elderly patients with early clinical stage breast cancer.

METHODS

Between 1982 and 1989, 73 women with American Joint Committee on Cancer Stage I/II, clinically negative axillary lymph nodes aged 65 years or older (median age, 74 years) were enrolled in a treatment program consisting of tumor excision, breast and regional lymph node irradiation, and, in 66 patients, tamoxifen. Patients were assessed for disease outcome and complications.

RESULTS

At a median follow-up of 54 months, 8-year rates of local and regional lymph node control were 92.5% and 100%, respectively. Eight-year probabilities of disease free, overall, and breast cancer specific survival were 84%, 52.5%, and 93.8%, respectively. There was minimal morbidity associated with either regional irradiation or tamoxifen.

CONCLUSIONS

An approach to early breast cancer in the elderly that seeks to limit the aggressiveness of local and systemic therapies appears to result in a satisfactory disease outcome with few complications.

摘要

背景

开展了一项前瞻性研究,以探索老年早期临床阶段乳腺癌患者的有限治疗方法。

方法

1982年至1989年期间,73例美国癌症联合委员会分期为I/II期、临床腋窝淋巴结阴性、年龄65岁及以上(中位年龄74岁)的女性纳入了一个治疗方案,该方案包括肿瘤切除、乳房及区域淋巴结放疗,66例患者还接受了他莫昔芬治疗。对患者的疾病转归和并发症进行评估。

结果

中位随访54个月时,局部和区域淋巴结8年控制率分别为92.5%和100%。无病、总生存和乳腺癌特异性生存的8年概率分别为84%、52.5%和93.8%。区域放疗或他莫昔芬相关的发病率均极低。

结论

一种旨在限制局部和全身治疗激进程度的老年早期乳腺癌治疗方法似乎能带来令人满意的疾病转归,且并发症较少。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验